BioAge halts obesity drug trial after safety concerns
BioPharma Dive - 07-Dec-2024Liver enzyme spikes in participants prompt a major setback for the biotech firm
Join the club for FREE to access the whole archive and other member benefits.
A news publisher offering in-depth coverage of the pharmaceutical and biotech industries
BioPharma Dive is a leading publication that provides in-depth news and analysis on the pharmaceutical and biotech industries. With a focus on the latest trends, scientific advancements, and regulatory updates, it serves as a go-to resource for professionals in the biopharma sector. The platform delivers expert insights on drug development, clinical trials, manufacturing, and market strategies, offering critical information for decision-makers and industry stakeholders.
Part of Industry Dive, a prominent business journalism company, BioPharma Dive combines breaking news coverage with investigative reporting and feature stories to keep its readers informed and ahead of industry changes. Its audience includes executives, researchers, and policymakers seeking reliable and comprehensive coverage of the dynamic biopharmaceutical landscape.
Visit website: https://www.biopharmadive.com/
biopharma-dive-biotech-and-pharma-news
Details last updated 08-Dec-2024
Liver enzyme spikes in participants prompt a major setback for the biotech firm